You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 8, August 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology, Other
 •Immunologic Disorders
 •Alert me on articles by topic

Topical Cidofovir

A Novel Treatment for Recalcitrant Molluscum Contagiosum in Children Infected With Human Immunodeficiency Virus 1

Jorge R. Toro, MD; Lauren V. Wood, MD; Nitin K. Patel, RPh; Maria L. Turner, MD
From the Dermatology Branch (Drs Toro and Turner), HIV and AIDS Malignancy Branch (Dr Wood), and Clinical Center Pharmacy Department (Mr Patel), National Cancer Institute, National Institutes of Health, Bethesda, Md.

Arch Dermatol. 2000;136:983-985.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF CASES

Two children with human immunodeficiency virus 1 (HIV-1) presented to the dermatology clinic for treatment of disseminated molluscum contagiosum (MC). Both children suffered from severe social isolation because of their facial disfigurement. Their MC lesions were refractory to numerous therapeutic modalities, including liquid nitrogen, cantharidin, and 0.05 % tretinoin gel. Both children had MC lesions, elevated viral loads, and low CD4 T-cell counts despite highly active antiretroviral therapy (HAART) for a median of 24 months. Patient 1, an 8-year-old African American boy, had a CD4 T-cell count of 329/µL and a viral load of 727,050 (log 5.86) HIV RNA copies/mL. Patient 2, a 4-year-old-Hispanic boy, had a CD4 T-cell count of 168/µL and a viral load of 429,976 (log 5.63) HIV RNA copies/mL

Both patients exhibited hundreds of umbilicated pearly and skin-colored papules disseminated . . . [Full Text of this Article]

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of Cidofovir in a Murine Model of Disseminated Progressive Vaccinia
Neyts et al.
Antimicrob. Agents Chemother. 2004;48:2267-2273.
ABSTRACT | FULL TEXT  

Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections
De Clercq
Clin. Microbiol. Rev. 2003;16:569-596.
ABSTRACT | FULL TEXT  

Effect of 5-Iodo-2'-Deoxyuridine on Vaccinia Virus (Orthopoxvirus) Infections in Mice
Neyts et al.
Antimicrob. Agents Chemother. 2002;46:2842-2847.
ABSTRACT | FULL TEXT  

Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses
Smee et al.
Antimicrob. Agents Chemother. 2002;46:1329-1335.
ABSTRACT | FULL TEXT  

Compounding of Topical Cidofovir
Goldblum and Zabawski
Arch Dermatol 2002;138:267-267.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.